Firstly, PSMA is thought to direct cellular growth and promote tumor progression by acting on glutamate receptors and activating the pro-survival protein kinase B (AKT)/phosphatidylinositol 3-kinase pathways [135]. This evidence concerns the gene FOLH1 and neoplasm.